Bemarituzumab as first-line treatment for locally advanced or metastatic gastric/gastroesophageal junction adenocarcinoma: final analysis of the randomized phase 2 FIGHT trial. - Wainberg ZA; Kang YK; Lee KW; Qin S; Yamaguchi K; Kim IH; Saeed A; Oh SC; Li J; Turk HM; Teixeira A; Hitre E; et al. (Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association, 2024)